Stacy C. Dilzer
Impact in
-
- Diabetes Treatment and Management
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Diabetes Treatment and Management 8
- Oncology 5
- Peptidase Inhibition and Analysis 5
- Co-authors
- Kenneth C. Lasseter (25 shared papers)Arthur Bergman (6 shared papers)Gary Herman (6 shared papers)John A. Wagner (5 shared papers)David L. Ebel (3 shared papers)Julie A. Stone (5 shared papers)Elizabeth Migoya (4 shared papers)Wei Zeng (4 shared papers)
- Journals
- The Journal of Clinical Pharmacology (7 papers)Antimicrobial Agents and Chemotherapy (2 papers)Biopharmaceutics & Drug Disposition (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Diabetes Obesity and Metabolism (1 paper)
- Partner nations
- United StatesSwitzerlandIreland
In The Last Decade
Stacy C. Dilzer
25 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 96
- Endocrinology, Diabetes and Metabolism 423
- Pharmacology 323
- Transplantation 40
- Pharmacology 121
- Infectious Diseases 234
Countries citing papers authored by Stacy C. Dilzer
This map shows the geographic impact of Stacy C. Dilzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacy C. Dilzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacy C. Dilzer more than expected).
Fields of papers citing papers by Stacy C. Dilzer
This network shows the impact of papers produced by Stacy C. Dilzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacy C. Dilzer. The network helps show where Stacy C. Dilzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Stacy C. Dilzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 246 | |
| 2 | 2006 | 147 | |
| 3 | 2007 | 127 | |
| 4 | 2004 | 111 | |
| 5 | 2001 | 76 | |
| 6 | 2004 | 74 | |
| 7 | 2007 | 69 | |
| 8 | 2007 | 58 | |
| 9 | Effect of moderate hepatic insufficiency on the pharmacokinetics of sitagliptin. | 2009 | 51 |
| 10 | 2007 | 49 | |
| 11 | 2001 | 47 | |
| 12 | 2016 | 42 | |
| 13 | 2013 | 29 | |
| 14 | 2005 | 23 | |
| 15 | 2012 | 23 | |
| 16 | 2003 | 19 | |
| 17 | Drug interactions between caspofungin and tacrolimus | 2001 | 17 |
| 18 | 2005 | 17 | |
| 19 | 1998 | 15 | |
| 20 | 2004 | 14 |
About Stacy C. Dilzer
Stacy C. Dilzer is a scholar working on Endocrinology, Diabetes and Metabolism, Oncology, Infectious Diseases, Epidemiology and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 1.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (8 papers), Peptidase Inhibition and Analysis (5 papers), Antifungal resistance and susceptibility (4 papers), Inflammatory mediators and NSAID effects (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Helminth infection and control (2 papers), Neuropeptides and Animal Physiology (2 papers) and Nematode management and characterization studies (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (423 citations), Pharmacology (323 citations), Transplantation (40 citations), Pharmacology (121 citations) and Infectious Diseases (234 citations). Stacy C. Dilzer has collaborated with scholars based in United States, Switzerland and Ireland. Frequent co-authors include Kenneth C. Lasseter, Arthur Bergman, Gary Herman, John A. Wagner, David L. Ebel, Julie A. Stone, Elizabeth Migoya, Wei Zeng, Li Chen and Patrick Larson. Their work appears in journals such as The Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Biopharmaceutics & Drug Disposition, Clinical Pharmacology & Therapeutics and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.